Advanced Biomed (ADVB) Cash from Operations (2024 - 2026)

Advanced Biomed has disclosed Cash from Operations across 3 years of filings, most recently posting 239775.0 for Q1 2026.

• Cash from Operations for Q1 2026 came in at 239775.0, up 95.59% year-over-year; the trailing twelve-month figure through Mar 2026 was 399541.0 (up 93.74% YoY), and the FY2025 annual result was 5825055.0, down 173.95% from the prior year.
• Cash from Operations came in at 239775.0 for Q1 2026 at Advanced Biomed, down from 363942.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 363942.0 in Q4 2025 to a low of 5437513.0 in Q1 2025.
• The 3-year median for Cash from Operations is 444496.0 (2024), against an average of 872524.0.
• Peak annual rise in Cash from Operations reached 181.88% in 2025, while the deepest fall reached 1956.41% in 2025.
• Advanced Biomed's Cash from Operations stood at 444496.0 in 2024, then surged by 181.88% to 363942.0 in 2025, then slumped by 165.88% to 239775.0 in 2026.
• The last three Cash from Operations figures came in at 239775.0 (Q1 2026), 363942.0 (Q4 2025), and 610342.0 (Q3 2025), per Business Quant data.